Opinion - Can innate immunity be enhanced to treat microbial infections?

被引:243
作者
Finlay, BB [1 ]
Hancock, REW [1 ]
机构
[1] Univ British Columbia, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1038/nrmicro908
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Innate immunity is a highly effective set of conserved mechanisms used by multicellular organisms to recognize and counter the constant threat of microbial infections. There is evidence to indicate that innate responses are key to controlling most infections, as well as contributing to inflammatory responses that are central components of disease. In addition to Toll-like-receptor-mediated effects, many other mechanisms are used to recognize and respond to microbial threats. Natural molecules such as CpG DNA and small cationic peptides trigger innate responses that help to control infection. This indicates there is potential to utilize such compounds to activate or enhance innate responses as antimicrobials. Harnessing this activity, without associated harmful inflammatory responses, is the main challenge.
引用
收藏
页码:497 / 504
页数:8
相关论文
共 63 条
[1]   Innate immunity via Toll-like receptors and Nod proteins [J].
Athman, R ;
Philpott, D .
CURRENT OPINION IN MICROBIOLOGY, 2004, 7 (01) :25-32
[2]   PEPTIDE DERIVATIVES OF 3 DISTINCT LIPOPOLYSACCHARIDE-BINDING PROTEINS INHIBIT LIPOPOLYSACCHARIDE-INDUCED TUMOR-NECROSIS-FACTOR-ALPHA SECRETION IN-VITRO [J].
BATTAFARANO, RJ ;
DAHLBERG, PS ;
RATZ, CA ;
JOHNSTON, JW ;
GRAY, BH ;
HASEMAN, JR ;
MAYO, KH ;
DUNN, DL .
SURGERY, 1995, 118 (02) :318-324
[3]   Innate immunity: an overview [J].
Beutler, B .
MOLECULAR IMMUNOLOGY, 2004, 40 (12) :845-859
[4]   Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2 [J].
Biragyn, A ;
Ruffini, PA ;
Leifer, CA ;
Klyushnenkova, E ;
Shakhov, A ;
Chertov, O ;
Shirakawa, AK ;
Farber, JM ;
Segal, DM ;
Oppenheim, JJ ;
Kwak, LW .
SCIENCE, 2002, 298 (5595) :1025-1029
[5]   The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes [J].
Bowdish, DME ;
Davidson, DJ ;
Speert, DP ;
Hancock, REW .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3758-3765
[6]  
Chan CC, 2000, ANN NY ACAD SCI, V923, P141
[7]   CpG DNA in the prevention and treatment of infections [J].
Dalpke, A ;
Zimmermann, S ;
Heeg, K .
BIODRUGS, 2002, 16 (06) :419-431
[8]   The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization [J].
Davidson, DJ ;
Currie, AJ ;
Reid, GSD ;
Bowdish, DME ;
MacDonald, KL ;
Ma, RC ;
Hancock, REW ;
Speert, DP .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :1146-1156
[9]   Treatment of infectious diseases with immunostimulatory oligodeoxynucleotides containing CpG motifs [J].
Dittmer, U ;
Olbrich, ARM .
CURRENT OPINION IN MICROBIOLOGY, 2003, 6 (05) :472-477
[10]   MAP kinases in the immune response [J].
Dong, C ;
Davis, RJ ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :55-72